231 related articles for article (PubMed ID: 36702635)
1. Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.
Vang A; Salem K; Fowler AM
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36702635
[TBL] [Abstract][Full Text] [Related]
2. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
[TBL] [Abstract][Full Text] [Related]
4. Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.
Albalawi IA; Mir R; Abu-Duhier FM
Endocr Metab Immune Disord Drug Targets; 2020; 20(5):760-770. PubMed ID: 31763970
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of progesterone receptor and ovarian cancer risk: a systemic review and meta-analysis.
Liao J; Ding D; Sun C; Weng D; Meng L; Chen G; Ma D
J Obstet Gynaecol Res; 2015 Feb; 41(2):178-87. PubMed ID: 25228088
[TBL] [Abstract][Full Text] [Related]
6. No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.
Qi XL; Yao J; Zhang Y
BMC Med Genet; 2017 Oct; 18(1):123. PubMed ID: 29084518
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
Liu T; Chen L; Sun X; Wang Y; Li S; Yin X; Wang X; Ding C; Li H; Di W
Tumour Biol; 2014 Mar; 35(3):2427-36. PubMed ID: 24197980
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.
Kanabekova P; Al-Awadi AM; Bauyrzhanova Z; Tahtouh T; Sarray S; Almawi WY
Gene; 2022 Apr; 820():146288. PubMed ID: 35143942
[TBL] [Abstract][Full Text] [Related]
9. Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.
Zhou C; Zou X; Wen X; Guo Z
PLoS One; 2022; 17(7):e0271265. PubMed ID: 35839271
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the progesterone receptor gene and susceptibility to recurrent pregnancy loss: a case-control study.
Bahia W; Finan RR; Al-Mutawa M; Haddad A; Soua A; Janhani F; Mahjoub T; Almawi WY
BJOG; 2018 May; 125(6):729-735. PubMed ID: 28972310
[TBL] [Abstract][Full Text] [Related]
11. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.
Gabriel CA; Mitra N; Demichele A; Rebbeck T
Breast Cancer Res Treat; 2013 Jun; 139(3):833-43. PubMed ID: 23764995
[TBL] [Abstract][Full Text] [Related]
12. Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.
Chaudhary S; Panda AK; Mishra DR; Mishra SK
PLoS One; 2013; 8(1):e53308. PubMed ID: 23349706
[TBL] [Abstract][Full Text] [Related]
13. The Alu-insertion progesterone receptor gene polymorphism is not associated with breast cancer: a meta-analysis.
Yao J; Qi XL; Zhang Y
BMC Med Genet; 2018 Jan; 19(1):16. PubMed ID: 29370776
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor variants associated with the PROGINS haplotype exhibit functional properties similar to those of wild-type progesterone receptor.
Stenzig J; Schweikert A; Piasecki A; Höppner G; Eschenhagen T; Rau T
Pharmacogenet Genomics; 2012 Aug; 22(8):629-41. PubMed ID: 22722322
[TBL] [Abstract][Full Text] [Related]
15. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
16. Effect of steroid hormone receptor gene variants PROGINS (Alu insertion) and PGR C/T (rs1042839) as a risk factor for recurrent pregnancy loss in Kashmiri population (North India).
Khan N; Zargar MH; Ahmed R; Godha M; Ahmad A; Afroze D; Masoodi SR
J Obstet Gynaecol Res; 2021 Dec; 47(12):4329-4339. PubMed ID: 34626148
[TBL] [Abstract][Full Text] [Related]
17. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
18. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor gene variants and risk of endometrial cancer.
O'Mara TA; Fahey P; Ferguson K; Marquart L; Lambrechts D; Despierre E; Vergote I; Amant F; Hall P; Liu J; Czene K; ; Rebbeck TR; ; ; ; Ahmed S; Dunning AM; Gregory CS; Shah M; ; Webb PM; Spurdle AB
Carcinogenesis; 2011 Mar; 32(3):331-5. PubMed ID: 21148628
[TBL] [Abstract][Full Text] [Related]
20. +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.
Kotsopoulos J; Tworoger SS; De Vivo I; Hankinson SE; Hunter DJ; Willett WC; Chen WY
Int J Cancer; 2009 Oct; 125(7):1685-91. PubMed ID: 19462450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
